Article

Range of ‘uninterrupted vision’ possible with inlay

Study patients with a near vision inlay implanted under a femtosecond flap achieved extended depth of focus that ranged from +1 to +3 D, said John A. Hovanesian, MD.

San Diego-Study patients with a near vision inlay implanted under a femtosecond flap achieved extended depth of focus that ranged from +1 to +3 D, said John A. Hovanesian, MD.

Participants in the multicenter, prospective, FDA investigational device exemption study had to be emmetropic with presbyopia that required a reading add form +1.5 to +2 D, said Dr. Hovanesian, in practice in Laguna Hills, CA.

The implant (Raindrop Near Vision Inlay, ReVision Optics) is designed to change the curvature of the overlying cornea creating a gradient of power that allows a full range of uninterrupted vision.

“We implanted the inlay in the non-dominant eye, and concentrated this evaluation on a sub-group of 30 patients from two clinical sites,” he said.

Sub-study endpoints included defocus curves and contrast sensitivity measured preoperatively and 12 months postoperatively. Uncorrected and best-corrected visual acuity (UCVA and BCVA, respectively) were measured with the ETDRS charts and collected in the Optec Vision Tester (Stereo Optical Co.) at near (40 cm), intermediate (80 cm), and distance (6 m) at preoperatively, 1 week, 1 month, 3 months, and 12 months postoperatively. Defocus curves and contrast sensitivity were measured as part of a substudy at preoperatively and 12 months.

More ASCRS 2015 coverage: Adequate suction does not guarantee safety in femto

At 12 months (n = 30), monocular near and intermediate visual acuities improved from preoperative levels of 20/72 (uncorrected near visual acuity) to 20/22. Uncorrected intermediate visual acuity improved from 20/46 to 20/26, Dr. Hovanesian said.

Binocularly, all subjects were 20/32 or better at near, 20/32 or better at intermediate, and 20/20 or better at distance.

Next: 'No statistical significance'

 

“There was no statistical significance between preop and 1 year postop for any of the test conditions at any of the spatial frequencies, with one exception,” Dr. Hovanesian said.

However, the difference was not deemed to be clinically significant, he added.

Defocus curve measurements showed an extended depth of focus with minus lenses when compared to preoperatively (20/40 or better from +1 to –3 D). Mesopic contrast sensitivity in the inlay eye showed no difference preoperatively to the final follow-up at 12 months, he said.

Overall patient satisfaction in this cohort of subjects was high at 93%.

“In short, the Raindrop Inlay modifies the shape of the central cornea and provides an uninterrupted transition from near to intermediate to distance vision,” he said.

This inlay is able to provide a 3.5 D range of functional vision, resulting in 20/40 or better, “without affecting contrast sensitivity in mesopic or photopic conditions, with and without glare,” he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.